Federica Barbagallo1, Bing Xu1, Gopireddy R Reddy1, Toni West1, Qingtong Wang1, Qin Fu1, Minghui Li1, Qian Shi1, Kenneth S Ginsburg1, William Ferrier1, Andrea M Isidori1, Fabio Naro1, Hemal H Patel1, Julie Bossuyt1, Donald Bers1, Yang K Xiang2. 1. From the Department of Pharmacology, University of California at Davis (F.B., B.X., G.R.R., T.W., Q.W., Q.F., M.L., Q.S., K.S.G., J.B., D.B., Y.K.X.); Department of Experimental Medicine (F.B., A.M.I.) and Department of Anatomical, Histological, Forensic, and Orthopedic Sciences (F.N.), Sapienza University of Rome, Italy; Department of Medicine and Epidemiology, School of Veterinary Medicine, and Surgical Research Facility, School of Medicine, University of California, Davis (W.F.); VA San Diego Healthcare System, La Jolla, CA (H.H.P.); Department of Anesthesiology, University of California, San Diego, La Jolla (H.H.P.); and VA Northern California Healthcare System, Mather (Y.K.X.). 2. From the Department of Pharmacology, University of California at Davis (F.B., B.X., G.R.R., T.W., Q.W., Q.F., M.L., Q.S., K.S.G., J.B., D.B., Y.K.X.); Department of Experimental Medicine (F.B., A.M.I.) and Department of Anatomical, Histological, Forensic, and Orthopedic Sciences (F.N.), Sapienza University of Rome, Italy; Department of Medicine and Epidemiology, School of Veterinary Medicine, and Surgical Research Facility, School of Medicine, University of California, Davis (W.F.); VA San Diego Healthcare System, La Jolla, CA (H.H.P.); Department of Anesthesiology, University of California, San Diego, La Jolla (H.H.P.); and VA Northern California Healthcare System, Mather (Y.K.X.). ykxiang@ucdavis.edu.
Abstract
RATIONALE: In heart failure, myofilament proteins display abnormal phosphorylation, which contributes to contractile dysfunction. The mechanisms underlying the dysregulation of protein phosphorylation on myofilaments is not clear. OBJECTIVE: This study aims to understand the mechanisms underlying altered phosphorylation of myofilament proteins in heart failure. METHODS AND RESULTS: We generate a novel genetically encoded protein kinase A (PKA) biosensor anchored onto the myofilaments in rabbit cardiac myocytes to examine PKA activity at the myofilaments in responses to adrenergic stimulation. We show that PKA activity is shifted from the sarcolemma to the myofilaments in hypertrophic failing rabbit myocytes. In particular, the increased PKA activity on the myofilaments is because of an enhanced β2 adrenergic receptor signal selectively directed to the myofilaments together with a reduced phosphodiesterase activity associated with the myofibrils. Mechanistically, the enhanced PKA activity on the myofilaments is associated with downregulation of caveolin-3 in the hypertrophic failing rabbit myocytes. Reintroduction of caveolin-3 in the failing myocytes is able to normalize the distribution of β2 adrenergic receptor signal by preventing PKA signal access to the myofilaments and to restore contractile response to adrenergic stimulation. CONCLUSIONS: In hypertrophic rabbit myocytes, selectively enhanced β2 adrenergic receptor signaling toward the myofilaments contributes to elevated PKA activity and PKA phosphorylation of myofilament proteins. Reintroduction of caveolin-3 is able to confine β2 adrenergic receptor signaling and restore myocyte contractility in response to β adrenergic stimulation.
RATIONALE: In heart failure, myofilament proteins display abnormal phosphorylation, which contributes to contractile dysfunction. The mechanisms underlying the dysregulation of protein phosphorylation on myofilaments is not clear. OBJECTIVE: This study aims to understand the mechanisms underlying altered phosphorylation of myofilament proteins in heart failure. METHODS AND RESULTS: We generate a novel genetically encoded protein kinase A (PKA) biosensor anchored onto the myofilaments in rabbit cardiac myocytes to examine PKA activity at the myofilaments in responses to adrenergic stimulation. We show that PKA activity is shifted from the sarcolemma to the myofilaments in hypertrophic failing rabbit myocytes. In particular, the increased PKA activity on the myofilaments is because of an enhanced β2 adrenergic receptor signal selectively directed to the myofilaments together with a reduced phosphodiesterase activity associated with the myofibrils. Mechanistically, the enhanced PKA activity on the myofilaments is associated with downregulation of caveolin-3 in the hypertrophic failing rabbit myocytes. Reintroduction of caveolin-3 in the failing myocytes is able to normalize the distribution of β2 adrenergic receptor signal by preventing PKA signal access to the myofilaments and to restore contractile response to adrenergic stimulation. CONCLUSIONS: In hypertrophic rabbit myocytes, selectively enhanced β2 adrenergic receptor signaling toward the myofilaments contributes to elevated PKA activity and PKA phosphorylation of myofilament proteins. Reintroduction of caveolin-3 is able to confine β2 adrenergic receptor signaling and restore myocyte contractility in response to β adrenergic stimulation.
Authors: Yogananda S Markandeya; Laura J Phelan; Marites T Woon; Alexis M Keefe; Courtney R Reynolds; Benjamin K August; Timothy A Hacker; David M Roth; Hemal H Patel; Ravi C Balijepalli Journal: J Biol Chem Date: 2015-07-13 Impact factor: 5.157
Authors: Cinzia Perrino; Sathyamangla V Naga Prasad; Jacob N Schroder; Jonathan A Hata; Carmelo Milano; Howard A Rockman Journal: Circulation Date: 2005-05-16 Impact factor: 29.690
Authors: Simon Bryant; Tomomi E Kimura; Cherrie H T Kong; Judy J Watson; Anabelle Chase; M Saadeh Suleiman; Andrew F James; Clive H Orchard Journal: J Mol Cell Cardiol Date: 2014-01-09 Impact factor: 5.000
Authors: Peter T Wright; Viacheslav O Nikolaev; Thomas O'Hara; Ivan Diakonov; Anamika Bhargava; Sergiy Tokar; Sophie Schobesberger; Andrew I Shevchuk; Markus B Sikkel; Ross Wilkinson; Natalia A Trayanova; Alexander R Lyon; Sian E Harding; Julia Gorelik Journal: J Mol Cell Cardiol Date: 2013-12-15 Impact factor: 5.000
Authors: Bence Hegyi; Julie Bossuyt; Kenneth S Ginsburg; Lynette M Mendoza; Linda Talken; William T Ferrier; Steven M Pogwizd; Leighton T Izu; Ye Chen-Izu; Donald M Bers Journal: Circ Arrhythm Electrophysiol Date: 2018-02
Authors: René Blöcher; Karen M Wagner; Raghavender R Gopireddy; Todd R Harris; Hao Wu; Bogdan Barnych; Sung Hee Hwang; Yang K Xiang; Ewgenij Proschak; Christophe Morisseau; Bruce D Hammock Journal: J Med Chem Date: 2018-04-10 Impact factor: 7.446